Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment

• Egile Nagusiak: Morgan T. Sutton (Egilea), David Fletcher (Egilea), Santosh K. Ghosh (Egilea), Aaron Weinberg (Egilea), Rolf van Heeckeren (Egilea), Sukhmani Kaur (Egilea), Zhina Sadeghi (Egilea), Adonis Hijaz (Egilea), Jane Reese (Egilea), Hillard M. Lazarus (Egilea), Donald P. Lennon (Egilea), Arnold I. Caplan (Egilea), Tracey L. Bonfield (Egilea)
• Formatua: Liburua
• Argitaratua: Hindawi Limited, 2016-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Cystic fibrosis (CF) is a genetic disease in which the battle between pulmonary infection and inflammation becomes the major cause of morbidity and mortality. We have previously shown that human MSCs (hMSCs) decrease inflammation and infection in the in vivo murine model of CF. The studies in this p...